ACZONE (Allergan, Inc.)
Welcome to the PulseAid listing for the ACZONE drug offered from Allergan, Inc.. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan, Inc. |
NON-PROPRIETARY NAME: | dapsone |
SUBSTANCE NAME: | DAPSONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-06-24 |
END MARKETING DATE: | 0000-00-00 |
ACZONE HUMAN PRESCRIPTION DRUG Details:
Item Description | ACZONE from Allergan, Inc. |
LABELER NAME: | Allergan, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/g) |
START MARKETING DATE: | 2009-06-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0023-3670_959d3017-c7b5-434e-bc00-370c3f27bb21 |
PRODUCT NDC: | 0023-3670 |
APPLICATION NUMBER: | NDA021794 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers: